ASSOCIATION OF RS2200733 POLYMORPHISM WITH ANTIARRHYTHMIC THERAPY AND PROGRESSION OF ATRIAL FIBRILLATION IN THE UZBEK POPULATIO

QR Code

ASSOCIATION OF RS2200733 POLYMORPHISM WITH ANTIARRHYTHMIC THERAPY AND PROGRESSION OF ATRIAL FIBRILLATION IN THE UZBEK POPULATIO

Aim: to study the association of rs2200733 polymorphism with antiarrhythmic efficacy of amiodarone, propafenone and allapinin in the prevention of atrial fibrillation (AF) progression.Material and methods. In order to comparatively evaluate the effectiveness of antiarrhythmic drugs in the prevention...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. D. Kurbanov, G. Zh. Abdullaeva, T. Z. Ganiev, A. A. Abdullaev, N. U. Zakirov
Format:	Article
Language:	Russian
Published:	InterMedservice 2020-12-01
Series:	Евразийский Кардиологический Журнал
Subjects:	atrial fibrillation atrial fibrillation progression rs2200733 polymorphism antiarrhythmic drugs
Online Access:	https://www.heartj.asia/jour/article/view/6234
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FIRST RUSSIA-BASED STUDY OF POLYMORPHISM rs2200733 CHROMOSOME 4q25 ASSOCIATION WITH DEVELOPMENT OF THE LONE ATRIAL FIBRILLATION
by: V. A. Shulman, et al.
Published: (2016-10-01)

Antiarrhythmic therapy in the treatment of atrial fibrillation: yesterday, today, tomorrow
by: V. I. Podzolkov, et al.
Published: (2019-06-01)

Association of Rate‐Control and Antiarrhythmic Medication Use and Risk of Ischemic Stroke and Death in Patients on Dialysis With Atrial Fibrillation
by: Benjamin Lidgard, et al.
Published: (2025-06-01)

Antiarrhythmic therapy for atrial fibrillation: current guidelines of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery (ESC/EACTS)
by: A. I. Tarzimanova, et al.
Published: (2021-09-01)

Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry
by: L. E. Korobchenko, et al.
Published: (2020-06-01)

ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICS
by: T. A. Rybakova, et al.
Published: (2018-08-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016-01-01)

ATRIAL FIBRILLATION: CURRENT PROBLEMS AND PROSPECTS OF MEDICAL CARE, TREATMENT AND PREVENTION
by: Ju. P. Skirdenko, et al.
Published: (2016-05-01)

Association Between Chromosome 4Q25 Polymorphism RS2200733 and the Incidence of Atrial Fibrillation in Bulgarian Patients
by: Dilyana Yakova-Hristova, et al.
Published: (2014-01-01)

Comparing the Impact of Different Antiarrhythmic Classes on Clinical Outcomes Following Atrial Fibrillation Catheter Ablation
by: Andrej Belančić, et al.
Published: (2025-07-01)

Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
by: M. H. Fedorova, et al.
Published: (2018-11-01)

Personalized Medicine in the Treatment of Atrial Fibrillation: Myth or Reality?
by: V. I. Podzolkov, et al.
Published: (2019-03-01)

Statins and their antiarrhythmic activity
by: N. Sh. Zagidullin, et al.
Published: (1970-01-01)

Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease
by: D. A. Tsaregorodtsev, et al.
Published: (2023-05-01)

Propafenone efficacy in paroxysmal atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2004-12-01)

PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION
by: V. A. Sulimov, et al.
Published: (2016-01-01)

Antiarrhythmic therapy choice in patients with left ventricular diastolic dysfunction and atrial fibrillation
by: A. V. Tarasov, et al.
Published: (1970-01-01)

CORRELATION BETWEEN HEART RHYTHM AND SYMPTOMS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AFTER CATHETER ABLATION AND ANTIARRHYTHMIC THERAPY BASED ON DATA OBTAINED FROM IMPLANTABLE CARDIAC MONITORS
by: A. A. Simonyan, et al.
Published: (2016-09-01)

Clinical study of Russian class III antiarrhythmic agent, nibentan, in supraventricular arrhythmia management
by: V. G. Valiev, et al.
Published: (2005-12-01)

Interactions between atrial fibrosis and inflammation in atrial fibrillation
by: Zhihua Pang, et al.
Published: (2025-07-01)

Paroxysmal atrial fibrillation: treatment choice
by: B. A. Tatarsky
Published: (2007-06-01)

STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION
by: S. G. Kanorsky, et al.
Published: (2017-08-01)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015-12-01)

CURRENT PRINCIPLES AND TRENDS OF ATRIAL FIBRILLATION PHARMACOTHERAPY
by: Yu. A. Bunin
Published: (2016-01-01)

Current Predictors of Atrial Fibrillation Progression
by: V. I. Podzolkov, et al.
Published: (2019-05-01)

Propafenone in complex anti-recurrent therapy of persistent atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2007-08-01)

Modern principles of atrial fibrillation therapy in patients with chronic heart failure
by: A. I. Tarzimanova, et al.
Published: (2005-06-01)

ATRIAL FIBRILLATION COMBINED WITH ARTERIAL HYPERTENSION AND OBESITY PARADOX
by: L. D. Khidirova, et al.
Published: (2019-03-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
by: K. A. Skiba, et al.
Published: (2003-06-01)

Avoiding anticoagulation drugs for postoperative atrial fibrillation enabled successful conservative treatment of left atrial dissection: a case report
by: Kentaro Kiryu, et al.
Published: (2021-05-01)

Predictors of paroxysmal thyrotoxic atrial fibrillation
by: L. N. Berestennikova, et al.
Published: (2011-10-01)

NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

The role of inflammatory markers in atrial fibrillation: a review
by: S. V. Grigoryan, et al.
Published: (2012-10-01)

POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY
by: R. D. Kurbanov, et al.
Published: (2015-12-01)

ATRIAL FIBRILLATION: FUNCTIONAL CLASSIFICATION
by: A. V. Germanov, et al.
Published: (2020-11-01)

UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
by: E. A. Protasova, et al.
Published: (2015-12-01)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015-12-01)

Atrial fibrillation: Yesterday, today, and tomorrow
by: S. G. Kanorskiy, et al.
Published: (2025-06-01)

Effect of Amiodarone, Sotalol and Bisoprolol on Heart Rate Variability in Patients with Atrial Fibrillation
by: E. P. Popova, et al.
Published: (2020-11-01)